Concord Medical Services (NYSE:CCM) Coverage Initiated at StockNews.com

Analysts at StockNews.com began coverage on shares of Concord Medical Services (NYSE:CCM) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the stock.

Concord Medical Services Price Performance

NYSE CCM opened at $5.70 on Friday. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.32 and a quick ratio of 0.30. Concord Medical Services has a fifty-two week low of $3.82 and a fifty-two week high of $26.70. The business has a fifty day moving average of $6.91 and a 200-day moving average of $6.71.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.